Prostate cancer mortality in Connecticut, Iowa and New Mexico African American men

Wingo, 2003, Long-term trends in cancer mortality in the United States, 1930–1998, Cancer, 97, 3133, 10.1002/cncr.11380 Eberhardt, 2001 Eberhardt, 2001 Gee, 1998, American urological association gallup survey: changes in diagnosis and management of prostate cancer and benign prostatic hyperplasia, and other practice trends from 1994 to 1997, J. Urol., 160, 1804, 10.1016/S0022-5347(01)62418-2 Middleton, 1995, Prostate cancer clinical guidelines panel summary report on the management of clinically localized prostate cancer, J. Urol., 154, 2144, 10.1016/S0022-5347(01)66718-1 Mettlin, 1998, The national cancer data base report on prostate carcinoma after the peak in incidence rates in the U.S., Cancer, 83, 1679, 10.1002/(SICI)1097-0142(19981015)83:8<1679::AID-CNCR24>3.0.CO;2-Y Hankey, 1999, Cancer surveillance series: interpreting trends in prostate cancer—Part I: evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates, JNCI, 91, 1017, 10.1093/jnci/91.12.1017 Lu-Yao, 1994, Changes in prostate cancer incidence and treatment in USA, Lancet, 343, 251, 10.1016/S0140-6736(94)91109-6 Brawley, 1997, Prostate carcinoma incidence and patient mortality, Cancer, 80, 1857, 10.1002/(SICI)1097-0142(19971101)80:9<1857::AID-CNCR26>3.0.CO;2-3 Mettlin, 1997, Results of hospital cancer registry surveys by the American College of Surgeons: outcomes of prostate cancer treatment by radical prostatectomy, Cancer, 80, 1875, 10.1002/(SICI)1097-0142(19971101)80:9<1875::AID-CNCR29>3.3.CO;2-V Potosky, 1995, The role of increasing detection in the rising incidence of prostate cancer, JAMA, 273, 548, 10.1001/jama.1995.03520310046028 Howard, 1992, A collaborative study of differences in the survival rates of black patients and white patients with cancer, Cancer, 69, 2349, 10.1002/1097-0142(19920501)69:9<2349::AID-CNCR2820690925>3.0.CO;2-7 Bradkey, 2001, Disparities in cancer diagnosis and survival, Cancer, 91, 178, 10.1002/1097-0142(20010101)91:1<178::AID-CNCR23>3.0.CO;2-S McDonald, 2001, The American Cancer Society addressing disparities and the disproportionate burden of cancer, Cancer Suppl., 91, 195, 10.1002/1097-0142(20010101)91:1+<195::AID-CNCR3>3.0.CO;2-0 1999, 422 Fowler, 1999, A prospective study of the serum prostate specific antigen concentrations and gleason histologic scores of Black and White men with prostate carcinoma, Cancer, 86, 836, 10.1002/(SICI)1097-0142(19990901)86:5<836::AID-CNCR20>3.0.CO;2-P Robbins, 1998, Race, prostate cancer survival, and membership in a large health maintenance organization, JNCI, 90, 986, 10.1093/jnci/90.13.986 Mettlin, 1997, The national cancer data base report on race, age, and region variations in prostate cancer treatment, Cancer, 80, 1261, 10.1002/(SICI)1097-0142(19971001)80:7<1261::AID-CNCR10>3.0.CO;2-5 Harlan, 1995, Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate, J. Clin. Oncol., 13, 93, 10.1200/JCO.1995.13.1.93 Underwood, 2004, Racial/ethnic disparities in the treatment of localized/regional prostate cancer, J. Urol., 171, 1504, 10.1097/01.ju.0000118907.64125.e0 Klabunde, 1998, Trends and black/white differences in treatment for nonmetastatic prostate cancer, Med. Care, 1337, 10.1097/00005650-199809000-00006 National Cancer Institute. A Guide to Using SEER*Stat, version 3.0. Bethesda, Maryland. Elliott, 1997, Cycles within the system: metropolitanisation and internal migration in the US, 1965–90, Urban Stud., 34, 21, 10.1080/0042098976258 Guidry, 1998, Cost considerations as potential barriers to cancer treatment, Cancer Pract., 6, 182, 10.1046/j.1523-5394.1998.006003182.x Breslow, 1987, Statistical methods in cancer research, 59, 59 Rothman, 1998 Smart, 1997, The results of prostate carcinoma screening in the US as reflected in the surveillance, epidemiology, and end results program, Cancer, 80, 1835, 10.1002/(SICI)1097-0142(19971101)80:9<1835::AID-CNCR23>3.0.CO;2-5 Mettlin, 1998, Why is the prostate cancer death rate declining in the United States?, Cancer, 82, 249, 10.1002/(SICI)1097-0142(19980115)82:2<249::AID-CNCR1>3.0.CO;2-M Hennekens, 1987 Jacobs, 2001, Receipt of cancer screening procedures among Hispanic and non-Hispanic health maintenance organization members, Cancer, 91, 257, 10.1002/1097-0142(20010101)91:1+<257::AID-CNCR15>3.0.CO;2-G Hall, 2003, Why patients choose prostatectomy or brachytherapy for localized prostate cancer: results of a descriptive survey, Urology, 61, 107, 10.1016/S0090-4295(02)02162-3 Roberts, 1999, Decline in prostate cancer mortality from 1980 to 1997, and an update on incidence trends in Olmsted County, Minnesota, J. Urol., 161, 529, 10.1016/S0022-5347(01)61941-4 Bartsch, 2001, Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria, Urology, 58, 417, 10.1016/S0090-4295(01)01264-X Bianco, 2002, Prostate cancer stage shift has eliminated the gap in disease-free survival in black and white American men after radical prostatectomy, J. Urol., 168, 479, 10.1016/S0022-5347(05)64662-9 Montie, 1995, Staging of prostate cancer: current TNM classification and future prospects for prognostic factors, Cancer, 75, 1814, 10.1002/1097-0142(19950401)75:7+<1814::AID-CNCR2820751610>3.0.CO;2-B Begg, 2002, Variations in morbidity after radical prostatectomy, N. Engl. J. Med., 346, 1138, 10.1056/NEJMsa011788 Lu-Yao, 2002, Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut, BMJ, 325, 740, 10.1136/bmj.325.7367.740 Centers for disease control and prevention, 1998, State specific prevalence estimates of uninsured and underinsured persons—behavioral risk factor surveillance system, 1995, MMWR, 47, 51 Perron, 2002, PSA screening and prostate cancer mortality, CMAJ, 166, 586 Oliver, 2000, Comparison of trends in prostate-cancer mortality in England and Wales and the USA, Lancet, 355, 1788, 10.1016/S0140-6736(00)02269-8